相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Edus H. Warren et al.
BLOOD (2012)
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study
Katharina Fleischhauer et al.
LANCET ONCOLOGY (2012)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi et al.
NATURE MEDICINE (2012)
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Claudio Anasetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
DRAMATIC REGRESSION OF CHRONIC LYMPHOCYTIC LEUKEMIA IN THE FIRST PATIENT TREATED WITH DONOR-DERIVED GENETICALLY-ENGINEERED ANTI-CD 19-CHIMERIC-ANTIGEN-RECEPTOR-EXPRESSING T CELLS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
J. N. Kochenderfer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
CTLA-4 Blockade following Relapse of Malignancy after Allogeneic Stem Cell Transplantation Is Associated with T Cell Activation But Not with Increased Levels of T Regulatory Cells
Jiehua Zhou et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
Anna Sergeeva et al.
BLOOD (2011)
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
Robert J. Soiffer et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of Recipient Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Marcello Rotta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Donor KIR Genes 2DL5A, 2DSI and 3DSI Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
Kate Stringaris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation
Marcello Rotta et al.
BLOOD (2010)
Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation
Itzel Bustos Villalobos et al.
BLOOD (2010)
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation
Kenneth P. Micklethwaite et al.
BLOOD (2010)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
CD8+ T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect
Andrew McLarnon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles
B. E. Shaw et al.
LEUKEMIA (2010)
CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
Sebastien Maury et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
What Is the Role for Donor Natural Killer Cells after Nonmyeloablative Conditioning?
Frederic Baron et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism
Takakazu Kawase et al.
BLOOD (2009)
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.
Luca Vago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
Vincent T. Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
National Marrow Donor Program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants
Robert A. Bray et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells (vol 118, pg 1099, 2008)
Yoshiyuki Takahashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation
Bronwen E. Shaw et al.
BLOOD (2007)
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
Takakazu Kawase et al.
BLOOD (2007)
Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani et al.
BLOOD (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
Jeffery S. Miller et al.
BLOOD (2007)
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Djordje Atanackovic et al.
BLOOD (2007)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
KIR Ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
Katharine C. Hsu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
HJ Deeg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation
RF Rousseau et al.
BLOOD (2006)
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial
JE Wagner et al.
LANCET (2005)
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation
S Verheyden et al.
LEUKEMIA (2005)
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma
S Neelapu et al.
BONE MARROW TRANSPLANTATION (2005)
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
KC Hsu et al.
BLOOD (2005)
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor
R Bellucci et al.
BLOOD (2005)
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1
LJN Cooper et al.
BLOOD (2005)
Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer
MHM Heemskerk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response
A Takami et al.
BONE MARROW TRANSPLANTATION (2004)
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
M Mielcarek et al.
BLOOD (2003)
A human minor histocompatibility antigen resulting from differential expression due to a gene deletion
M Murata et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
WAE Marijt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
A Gratwohl et al.
BLOOD (2002)
Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion
B Kircher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing
AG Brickner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
JC Boyington et al.
NATURE (2000)
Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma
R Cabrera et al.
BONE MARROW TRANSPLANTATION (2000)
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
CJ Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
JJ Molldrem et al.
NATURE MEDICINE (2000)
分享论文
